Leung, Elaine Lai-Han <br/><br/>
SRC promotes survival and invasion of lung cancers with epidermal growth factor receptor abnormalities and is a potential candidate for molecular-targeted therapy.  [electronic resource] 

 -  Molecular cancer research : MCR  Jun 2009 
 - 923-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3125 
<br/><br/><label>Standard No.: </label>10.1158/1541-7786.MCR-09-0003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Carcinoma, Non-Small-Cell Lung--enzymology<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>ErbB Receptors--antagonists & inhibitors<br/>Gefitinib<br/>Gene Amplification<br/>Humans<br/>Immunohistochemistry<br/>Lung Neoplasms--enzymology<br/>Mutation<br/>Neoplasm Invasiveness<br/>Phosphorylation--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Quinazolines--pharmacology<br/>RNA, Small Interfering--genetics<br/>Reproducibility of Results<br/>src-Family Kinases--antagonists & inhibitors